ACADIA PHARMACEUTICALS INC

ACAD

ACADIA PHARMACEUTICALS INC

ACAD

Insider Sentiment (TTM):

Last Purchase:-Last Sale:2026-06-26Shares Purchased (TTM):0Shares Sold (TTM):127,030

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:162,659,813Shares Outstanding:170,517,000Institutional Ownership Pct.:95.39%

Earnings Market Reaction:

Filing Date:2026-05-07Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Pharmaceutical Preparations

LLY JNJ ABBV MRK ABT PFE

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Assets
Cash And Cash Equivalents At Carrying Value	282	178	258	254	218	320	155	177	205	189	98	108
Available For Sale Securities Debt Securities Curr…	569	642	589	508	464	436	410	324	266	250	248	267
Accounts Receivable Net Current	135	121	116	108	106	99	98	104	95	98	93	82
Interest Receivable Current	13	27	24	12	8	6	12	7	5	4	2	2
Prepaid Expense Current	65	60	61	53	53	56	52	46	43	39	38	24
Assets Current	1,096	1,062	1,076	961	871	938	788	729	675	616	499	493
Property Plant And Equipment Net	15	8	4	4	3	4	4	4	4	5	5	5
Operating Lease Right Of Use Asset	46	47	50	51	51	47	44	52	54	52	51	52
Finite Lived Intangible Assets Net	106	109	112	114	117	120	106	108	110	65	67	68
Restricted Cash Noncurrent	8	8	9	9	9	9	9	6	6	6	6	8
Inventory For Long Term Contracts Or Programs	81	77	77	84	80	70	26	15	5	5	5	5
Deferred Income Tax Assets Net	250	250	-	-	-	0	-	-	-	-	-	-
Other Assets Noncurrent	4	4	3	2	1	0	0	0	0	0	0	11
Assets	1,605	1,564	1,331	1,226	1,132	1,188	977	914	855	749	633	643
Liabilities And Stockhold…
Accounts Payable Current	12	11	22	20	18	16	19	20	19	18	12	19
Accrued Liabilities Current	293	266	335	310	284	379	325	318	311	237	197	169
Liabilities Current	306	277	357	330	303	395	344	338	331	254	210	188
Operating Lease Liability Noncurrent	39	41	43	45	45	42	40	47	49	48	48	50
Other Liabilities Noncurrent	13	19	14	29	20	18	15	12	11	15	13	9
Liabilities	357	337	413	403	367	455	400	397	391	317	270	247
Stockholders Equity
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital Common Stock	3,058	3,039	3,003	2,981	2,950	2,937	2,924	2,898	2,879	2,863	2,839	2,808
Retained Earnings Accumulated Deficit	-1,810	-1,813	-2,087	-2,159	-2,185	-2,204	-2,348	-2,381	-2,414	-2,431	-2,477	-2,411
Accumulated Other Comprehensive Income Loss Net Of…	-1	1	1	0	0	0	1	-0	-0	0	-0	-1
Stockholders Equity	1,248	1,227	917	822	765	733	577	517	464	432	362	396
Liabilities And Stockholders Equity	1,605	1,564	1,331	1,226	1,132	1,188	977	914	855	749	633	643
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Authorized	5	5	5	5	5	5	5	5	5	5	5	5
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	225	225	225	225	225	225	225	225	225	225	225	225
Common Stock Shares Issued	171	170	169	169	167	167	166	166	165	165	164	163
Shares Outstanding	171	170	169	169	167	167	166	166	165	165	164	163

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-3.99%	12.23%	10.11%	-	-	-	-	-	-	-	-	-
2025	27.41%	30.66%	37.33%	6.52%	-13.73%	-9.75%	15.66%	27.58%	23.97%	-15.83%	-10.02%	-13.15%
2024	-0.72%	6.84%	25.84%	9.29%	3.43%	-5.47%	-5.12%	-1.45%	8.55%	-13.19%	-23.84%	15.10%
2023	14.20%	11.14%	34.76%	5.15%	-13.38%	-18.53%	-7.40%	30.45%	13.38%	-24.42%	-29.18%	-37.73%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	3.59	3.83	3.02	2.91	2.88	2.38	2.29	2.16	2.04	2.42	2.38	2.62
Quick Ratio	3.38	3.62	2.85	2.75	2.70	2.24	2.14	2.02	1.91	2.27	2.20	2.49
Working Capital	790.49M	785.00M	719.84M	630.53M	568.41M	543.45M	444.34M	391.07M	344.70M	361.87M	289.57M	304.69M
Leverage & Debt
Debt to Equity	0.29	0.27	0.45	0.49	0.48	0.62	0.69	0.77	0.84	0.73	0.75	0.62
Interest Coverage TTM	2.54	3.30	7.93	8.24	8.43	9.07	4.84	1.10	-0.24	-4.26	-9.59	-8.93
Debt Ratio	0.22	0.22	0.31	0.33	0.32	0.38	0.41	0.43	0.46	0.42	0.43	0.38
Efficiency & Turnover
Asset Turnover TTM	0.80	0.78	0.91	0.95	1.00	0.99	1.15	1.14	1.08	1.09	1.02	0.88
Days Sales Outstanding TTM	40.17	37.50	37.31	37.83	36.72	37.54	37.51	38.03	36.02	40.31	42.90	49.63
Receivables Turnover TTM	9.09	9.73	9.78	9.65	9.94	9.72	9.73	9.60	10.13	9.05	8.51	7.35
Per Share Metrics
Diluted EPS TTM	2.18	2.30	1.53	1.32	1.37	1.36	0.77	0.18	-0.01	-0.37	-0.91	-0.67
Free Cash Flow Per Share TTM	0.67	0.04	0.59	0.53	0.30	0.95	1.22	0.49	0.14	-0.14	-0.81	-0.45
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	91.47%	91.69%	91.92%	91.97%	92.04%	91.46%	91.61%	91.72%	92.27%	94.27%	95.86%	97.52%
Operating Profit Margin TTM	7.39%	9.78%	23.01%	23.24%	23.58%	24.10%	12.08%	2.56%	-0.56%	-10.10%	-24.43%	-23.14%
Net Profit Margin TTM	34.30%	36.49%	24.94%	21.80%	22.97%	23.64%	13.83%	3.43%	-0.21%	-8.44%	-23.55%	-20.12%
Growth Metrics
Net Revenue Growth (1Y)	9.93%	11.87%	12.69%	14.41%	22.42%	31.85%	47.06%	61.65%	56.43%	40.45%	23.54%	7.51%
Net Income Growth (1Y)	64.12%	72.66%	103.24%	626.84%	-13,484.97%	-469.50%	-186.36%	-127.58%	-98.83%	-71.62%	-31.53%	-45.84%
EPS Growth (1Y)	60.55%	69.96%	99.79%	616.99%	-13,323.68%	-465.27%	-185.45%	-127.23%	-98.85%	-71.99%	-32.53%	-46.44%
Valuation Metrics
P/E TTM	10.10	11.50	13.80	16.29	12.11	13.43	19.86	88.02	-1,781.94	-83.69	-23.00	-35.33
P/B TTM	3.04	3.66	3.93	4.40	3.62	4.15	4.42	5.21	6.57	11.88	9.45	9.89
P/S TTM	3.47	4.20	3.44	3.55	2.78	3.17	2.75	3.02	3.74	7.06	5.42	7.11
Market Cap	3.80B	4.50B	3.60B	3.62B	2.77B	3.04B	2.55B	2.69B	3.05B	5.13B	3.42B	3.91B
Enterprise Value	3.51B	4.32B	3.34B	3.37B	2.55B	2.72B	2.40B	2.51B	2.84B	4.94B	3.32B	3.81B
Calculated Values
Free Cash Flow TTM	113.59M	6.31M	98.97M	88.25M	49.60M	157.20M	202.66M	80.48M	23.66M	-23.35M	-132.59M	-74.31M
Net Debt	-282.21M	-177.70M	-258.00M	-253.64M	-217.70M	-319.59M	-155.15M	-177.13M	-204.75M	-188.66M	-98.19M	-107.94M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-26Sale

Owner: Kihara, James

Title: PRINCIPAL ACCOUNTING OFFICER

Shares: 11,421

Price/Share: $26.08

Value: $297,859.68

Shares Owned: 13,088

Relationship: Officer

Ownership: Direct

2026-05-26Sale

Owner: Kihara, James

Title: PRINCIPAL ACCOUNTING OFFICER

Shares: 5,401

Price/Share: $21.18

Value: $114,393.18

Shares Owned: 24,509

Relationship: Officer

Ownership: Direct

2026-05-04Sale

Owner: Schneyer, Mark C.

Title: EVP, CHIEF FINANCIAL OFFICER

Shares: 3,506

Price/Share: $21.79

Value: $76,395.74

Shares Owned: 66,145

Relationship: Officer

Ownership: Direct

2026-05-04Sale

Owner: Kihara, James

Title: PRINCIPAL ACCOUNTING OFFICER

Shares: 1,332

Price/Share: $21.79

Value: $29,024.28

Shares Owned: 29,129

Relationship: Officer

Ownership: Direct

2026-04-07Sale

Owner: Kihara, James

Title: PRINCIPAL ACCOUNTING OFFICER

Shares: 1,030

Price/Share: $22.20

Value: $22,866.00

Shares Owned: 27,865

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-26	Kihara, James	Officer	PRINCIPAL ACCOUNTING OFFICER	Direct	Sale	11,421	26.08	$297,859.68	13,088	4
2026-05-26	Kihara, James	Officer	PRINCIPAL ACCOUNTING OFFICER	Direct	Sale	5,401	21.18	$114,393.18	24,509	4
2026-05-04	Schneyer, Mark C.	Officer	EVP, CHIEF FINANCIAL OFFICER	Direct	Sale	3,506	21.79	$76,395.74	66,145	4
2026-05-04	Kihara, James	Officer	PRINCIPAL ACCOUNTING OFFICER	Direct	Sale	1,332	21.79	$29,024.28	29,129	4
2026-04-07	Kihara, James	Officer	PRINCIPAL ACCOUNTING OFFICER	Direct	Sale	1,030	22.20	$22,866.00	27,865	4
2026-04-07	Schneyer, Mark C.	Officer	EVP, CHIEF FINANCIAL OFFICER	Direct	Sale	2,709	22.20	$60,139.80	62,836	4
2026-03-26	Kihara, James	Officer	PRINCIPAL ACCOUNTING OFFICER	Direct	Sale	1,109	21.69	$24,054.21	26,885	4
2026-03-26	Schneyer, Mark C.	Officer	EVP, CHIEF FINANCIAL OFFICER	Direct	Sale	3,208	21.68	$69,549.44	60,269	4
2026-03-25	Owen, Adams Catherine	Director,Officer	Chief Executive Officer	Direct	Sale	11,641	21.47	$249,932.27	14,803	4
2026-03-25	Rhodes, Jennifer J	Officer	EVP, CHIEF LEGAL OFFICER, SEC	Direct	Sale	3,844	21.47	$82,530.68	11,280	4
2026-03-25	Thompson, Elizabeth H.Z.	Officer	EVP, Head of Research & Dev	Direct	Sale	3,435	21.47	$73,749.45	3,280	4
2026-02-09	Rhodes, Jennifer J	Officer	EVP, CHIEF LEGAL OFFICER, SEC	Direct	Sale	6,950	23.38	$162,491.00	7,609	4
2025-11-18	Kihara, James	Officer	PRINCIPAL ACCOUNTING OFFICER	Direct	Sale	4,084	23.69	$96,749.96	25,058	4
2025-11-18	Schneyer, Mark C.	Officer	EVP, CHIEF FINANCIAL OFFICER	Direct	Sale	10,262	23.69	$243,106.78	53,338	4
2025-11-10	Daly, James M	Director	-	Direct	Sale	30,000	22.37	$671,100.00	4,041	4
2025-09-15	Schneyer, Mark C.	Officer	EVP, CHIEF FINANCIAL OFFICER	Direct	Sale	3,498	23.65	$82,727.70	43,447	4
2025-09-02	Garofalo, Elizabeth A.	Director	-	Direct	Sale	1,600	25.98	$41,568.00	25,382	4
2025-08-18	Schneyer, Mark C.	Officer	EVP, CHIEF FINANCIAL OFFICER	Direct	Sale	22,000	25.18	$553,960.00	40,130	4
2025-06-04	Brege, Laura	Director	-	Direct	Sale	14,446	21.78	$314,633.88	15,095	4
2025-05-16	Kihara, James	Officer	PRINCIPAL ACCOUNTING OFFICER	Direct	Sale	4,000	22.50	$90,000.00	20,395	4
2025-05-16	Schneyer, Mark C.	Officer	EVP, CHIEF FINANCIAL OFFICER	Direct	Sale	2,000	25.00	$50,000.00	62,130	4
2025-05-02	Schneyer, Mark C.	Officer	EVP, CHIEF FINANCIAL OFFICER	Direct	Sale	3,498	14.60	$51,070.80	62,773	4
2025-05-02	Kihara, James	Officer	PRINCIPAL ACCOUNTING OFFICER	Direct	Sale	1,327	14.60	$19,374.20	23,526	4
2025-04-08	Schneyer, Mark C.	Officer	EVP, CHIEF FINANCIAL OFFICER	Direct	Sale	2,708	14.82	$40,132.56	59,456	4
2025-04-08	Kihara, James	Officer	PRINCIPAL ACCOUNTING OFFICER	Direct	Sale	1,028	14.82	$15,234.96	22,257	4
2025-03-26	Schneyer, Mark C.	Officer	EVP, CHIEF FINANCIAL OFFICER	Direct	Sale	3,171	17.05	$54,065.55	56,889	4
2025-03-26	Kihara, James	Officer	PRINCIPAL ACCOUNTING OFFICER	Direct	Sale	1,095	17.05	$18,669.75	21,275	4
2025-03-05	Garofalo, Elizabeth A.	Director	-	Direct	Sale	4,919	18.23	$89,673.37	17,595	4
2025-02-24	Schneyer, Mark C.	Officer	EVP, CHIEF FINANCIAL OFFICER	Direct	Sale	773	19.96	$15,429.08	53,882	4
2025-02-24	Kihara, James	Officer	PRINCIPAL ACCOUNTING OFFICER	Direct	Sale	475	19.96	$9,481.00	20,228	4
2024-11-19	Kihara, James	Officer	PRINCIPAL ACCOUNTING OFFICER	Direct	Sale	4,073	16.81	$68,467.13	19,863	4
2024-11-19	Schneyer, Mark C.	Officer	EVP, CHIEF FINANCIAL OFFICER	Direct	Sale	10,259	16.81	$172,453.79	53,302	4
2024-11-19	Teehan, Brendan	Officer	EVP, COO, HEAD OF COMMERCIAL	Direct	Sale	10,329	16.81	$173,630.49	62,105	4
2024-08-19	Davis, Stephen	Director,Officer	CEO	Direct	Sale	31,747	15.28	$485,094.16	186,555	4
2024-08-19	Schneyer, Mark C.	Officer	EVP, CHIEF FINANCIAL OFFICER	Direct	Sale	9,733	15.28	$148,720.24	43,735	4
2024-08-19	Teehan, Brendan	Officer	EVP, COO, HEAD OF COMMERCIAL	Direct	Sale	9,534	15.28	$145,679.52	52,177	4
2024-06-10	Schneyer, Mark C.	Officer	EVP, CHIEF FINANCIAL OFFICER	Direct	Sale	975	14.79	$14,420.25	34,564	4
2024-05-02	Teehan, Brendan	Officer	EVP, COO, HEAD OF COMMERCIAL	Direct	Sale	3,477	16.94	$58,900.38	42,133	4
2024-05-02	Davis, Stephen	Director,Officer	CEO	Direct	Sale	11,427	16.94	$193,573.38	155,231	4
2024-05-02	Schneyer, Mark C.	Officer	EVP, CHIEF FINANCIAL OFFICER	Direct	Sale	3,503	16.94	$59,340.82	32,053	4
2024-05-02	Kihara, James	Officer	PRINCIPAL ACCOUNTING OFFICER	Direct	Sale	1,326	16.94	$22,462.44	14,370	4
2024-04-08	Kihara, James	Officer	PRINCIPAL ACCOUNTING OFFICER	Direct	Sale	1,790	17.87	$31,987.30	13,100	4
2024-04-08	Davis, Stephen	Director,Officer	CEO	Direct	Sale	26,574	17.87	$474,877.38	144,267	4
2024-04-08	Teehan, Brendan	Officer	EVP, COO, HEAD OF COMMERCIAL	Direct	Sale	2,568	17.87	$45,890.16	38,796	4
2024-04-08	Schneyer, Mark C.	Officer	EVP, CHIEF FINANCIAL OFFICER	Direct	Sale	2,716	17.87	$48,534.92	28,742	4
2024-03-27	Davis, Stephen	Director,Officer	CEO	Direct	Sale	17,714	17.90	$317,080.60	118,842	4
2024-03-27	Teehan, Brendan	Officer	EVP, COO, HEAD OF COMMERCIAL	Direct	Sale	5,140	17.90	$92,006.00	36,340	4
2024-03-27	Schneyer, Mark C.	Officer	EVP, CHIEF FINANCIAL OFFICER	Direct	Sale	5,434	17.90	$97,268.60	26,183	4
2024-02-26	Schneyer, Mark C.	Officer	EVP, CHIEF FINANCIAL OFFICER	Direct	Sale	772	24.67	$19,045.24	21,067	4
2024-02-26	Kihara, James	Officer	PRINCIPAL ACCOUNTING OFFICER	Direct	Sale	474	24.67	$11,693.58	11,391	4
2024-02-26	Davis, Stephen	Director,Officer	CEO	Direct	Sale	5,577	24.67	$137,584.59	101,890	4
2024-02-26	Teehan, Brendan	Officer	EVP, COO, HEAD OF COMMERCIAL	Direct	Sale	624	24.67	$15,394.08	31,432	4
2024-01-08	Teehan, Brendan	Officer	EVP, COO, Head of Commercial	Direct	Sale	731	29.96	$21,900.76	30,949	4
2024-01-08	Davis, Stephen	Director,Officer	CEO	Direct	Sale	3,732	29.96	$111,810.72	96,521	4
2024-01-08	Kim, Austin D.	Officer	EVP,General Counsel, Secretary	Direct	Sale	590	29.96	$17,676.40	46,901	4
2023-12-15	Kihara, James	Officer	Principal Accounting Officer	Direct	Sale	2,000	28.30	$56,600.00	11,025	4
2023-11-20	Schneyer, Mark C.	Officer	EVP, Chief Financial Officer	Direct	Sale	5,108	22.64	$115,645.12	20,486	4
2023-11-20	Kihara, James	Officer	Principal Accounting Officer	Direct	Sale	1,985	22.64	$44,940.40	13,025	4
2023-11-20	Teehan, Brendan	Officer	EVP, COO, Head of Commercial	Direct	Sale	4,960	22.64	$112,294.40	30,393	4
2023-10-06	Davis, Stephen	Director,Officer	CEO	Direct	Sale	51,563	21.96	$1,132,323.48	89,131	4
2023-10-06	Kim, Austin D.	Officer	EVP,General Counsel, Secretary	Direct	Sale	16,369	21.96	$359,463.24	45,857	4
2023-09-15	Kihara, James	Officer	Principal Accounting Officer	Direct	Sale	2,000	25.88	$51,760.00	10,778	4
2023-08-21	Schneyer, Mark C.	Officer	EVP, Chief Financial Officer	Direct	Sale	10,000	29.00	$290,000.00	15,682	4
2023-07-14	Davis, Stephen	Director,Officer	CEO	Direct	Sale	100,000	30.04	$3,004,000.00	36,695	4
2023-07-11	Davis, Stephen	Director,Officer	CEO	Direct	Sale	16,498	25.00	$412,450.00	91,799	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

95.39%

Inst. Shares: 162,659,813

Shares Outstanding: 170,517,000

2025-12-31

97.50%

Inst. Shares: 164,142,601

Shares Outstanding: 168,356,000

2025-09-30

97.68%

Inst. Shares: 164,913,463

Shares Outstanding: 168,836,000

2025-06-30

99.62%

Inst. Shares: 167,196,376

Shares Outstanding: 167,827,000

2025-03-31

101.27%

Inst. Shares: 168,928,566

Shares Outstanding: 166,808,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	162,659,813	170,517,000	95.39%
2025-12-31	164,142,601	168,356,000	97.50%
2025-09-30	164,913,463	168,836,000	97.68%
2025-06-30	167,196,376	167,827,000	99.62%
2025-03-31	168,928,566	166,808,000	101.27%
2024-12-31	157,881,235	165,717,000	95.27%
2024-09-30	151,819,357	165,974,000	91.47%
2024-06-30	157,744,834	165,551,000	95.28%
2024-03-31	153,280,591	164,798,000	93.01%
2023-12-31	152,094,474	163,819,000	92.84%
2023-09-30	147,582,957	164,234,000	89.86%
2023-06-30	149,923,112	163,458,000	91.72%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

ACADIA PHARMACEUTICALS INC (ACAD) — SEC Financial Statements & Analysis

ACADIA PHARMACEUTICALS INC (ACAD) is a pharmaceutical preparations company, incorporated in DE. ACADIA PHARMACEUTICALS INC trades on Nasdaq as: ACAD. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), ACADIA PHARMACEUTICALS INC reported a 9.93% year-over-year revenue growth, a Gross Profit Margin of 91.47% (TTM), a Debt-to-Equity ratio of 0.29x, a Price-to-Sales (P/S) ratio of 3.47x (TTM), a Price-to-Book (P/B) ratio of 3.04 (TTM), at a market cap of $3.80B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 9.93%
Gross Profit Margin TTM: 91.47%
Debt To Equity: 0.29x
P/S TTM: 3.47x
P/B TTM: 3.04
Market Cap: $3.80B

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is ACADIA PHARMACEUTICALS INC in?

ACADIA PHARMACEUTICALS INC (ACAD) operates in the Pharmaceutical Preparations industry.

What is ACAD's market cap?

ACADIA PHARMACEUTICALS INC (ACAD) has a market capitalization of $3.80B as of 2026-03-31.

What is ACAD's P/E ratio?

ACADIA PHARMACEUTICALS INC (ACAD)'s trailing twelve month P/E ratio is 10.10x as of 2026-03-31.

What exchange does ACAD trade on?

ACADIA PHARMACEUTICALS INC (ACAD) trades on the Nasdaq.

Where is ACADIA PHARMACEUTICALS INC incorporated?

ACADIA PHARMACEUTICALS INC is incorporated in DE.

ACADIA PHARMACEUTICALS INC (ACAD) — SEC Financial Statements & Analysis

Frequently Asked Questions

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.